Stelara

Active Ingredient(s): Ustekinumab
FDA Approved: * September 25, 2009
Pharm Company: * CENTOCOR ORTHO BIOTECH INC
Category: Immunosuppressive

Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[5] targeting both IL-12 and IL-23.[6] Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to m... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Stelara 130 mg/26ml Intravenous Solution

NDC: 57894-054

Labeler:

Janssen Biotech, Inc.

Stelara 45 mg/.5ml Subcutaneous Injection, Solution

NDC: 57894-060

Labeler:

Janssen Biotech, Inc.

Stelara 90 mg/ml Subcutaneous Injection, Solution

NDC: 57894-061

Labeler:

Janssen Biotech, Inc.

Dosage List

Popular Topics